Interferon Treatment in Patients with Hypereosinophilia

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|3|429-432

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.3, 2011-03, pp. : 429-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon- Treatment of Patients with Hepatitis C: The Role of a Comprehensive Risk-Benefit Assessment

By Muhamad Aly Rifai   Loftis Jennifer M.   Hauser Peter  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 719-721

Adis International

Access to resources Recommend Favorite

Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients: A 1-Year, Observational Cohort Study

By Comini-Frota Elizabeth R.  

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 971-981

Adis International

Access to resources Recommend Favorite

Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma

By Zbrozek Arthur S.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 577-584

Adis International

Access to resources Recommend Favorite

Artificial Neural Networks for the Prediction of Response to Interferon Plus Ribavirin Treatment in Patients with Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-01 ,pp. : 2101-2109

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects

By  

Current Drug Abuse Reviews, Vol. 1, Iss. 2, 2008-06 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite